American International Group, Inc. Albireo Pharma, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$18.01 - $23.78 $7,960 - $10,510	442 Added 5.41%	8,613 $186,000
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $1,893 - $3,058	116 Added 1.44%	8,171 $158,000
Q2 2022 Aug 12, 2022	SELL	$18.54 - $37.29 $5,969 - $12,007	-322 Reduced 3.84%	8,055 $160,000
Q1 2022 May 13, 2022	SELL	$23.94 - $33.74 $14,100 - $19,872	-589 Reduced 6.57%	8,377 $250,000
Q4 2021 Feb 11, 2022	SELL	$21.19 - $31.29 $5,700 - $8,417	-269 Reduced 2.91%	8,966 $209,000

Q3 2021 Nov 12, 2021	SELL	$27.36 - $35.98 $5,991 - $7,879	-219 Reduced 2.32%	9,235 $288,000
Q2 2021 Aug 13, 2021	SELL	$28.9 - $36.87 $12,080 - $15,411	-418 Reduced 4.23%	9,454 $333,000
Q1 2021 May 07, 2021	BUY	$32.03 - $42.85 $832 - $1,114	26 Added 0.26%	9,872 $348,000
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $59,743 - $79,808	1,893 Added 23.8%	9,846 $369,000
Q3 2020 Nov 04, 2020	SELL	$23.19 - $41.61 $4,174 - $7,489	-180 Reduced 2.21%	7,953 $265,000
Q2 2020 Aug 12, 2020	BUY	$14.82 - $29.92 $8,580 - $17,323	579 Added 7.66%	8,133 $215,000
Q1 2020 May 04, 2020	BUY	$11.67 - $27.23 $8,635 - $20,150	740 Added 10.86%	7,554 $124,000
Q4 2019 Feb 05, 2020	SELL	$16.92 - $28.96 $964 - $1,650	-57 Reduced 0.83%	6,814 $173,000
Q3 2019 Nov 08, 2019	BUY	$20.0 - $31.88 $6,100 - $9,723	305 Added 4.65%	6,871 $137,000
Q2 2019 Aug 13, 2019	BUY	$30.67 - $37.86 $23,247 - $28,697	758 Added 13.05%	6,566 $212,000
Q1 2019 May 06, 2019	SELL	$22.22 - $32.21 $4,177 - $6,055	-188 Reduced 3.14%	5,808 $187,000
Q4 2018 Feb 13, 2019	SELL	$20.9 - $32.57 $982 - $1,530	-47 Reduced 0.78%	5,996 $147,000
Q3 2018 Nov 09, 2018	BUY	$29.29 - $36.87 $3,163 - $3,981	108 Added 1.82%	6,043 $199,000
Q2 2018 Aug 08, 2018	BUY	$28.9 - $37.31 $171,521 - $221,434	5,935 New	5,935 $211,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account